medication for opioid use disorder (TMOUD) has become more prevalent
during the COVID-19 pandemic, particularly in North America. This is
considered a positive development as TMOUD has the potential to increase
access to evidence-based treatment for a population heavily affected by
the opioid crisis and consequent rising mortality and morbidity rates
in relation to opioid use disorder. Despite the increase in the use of
TMOUD, there are no established service- and process-focused models to
guide the implementation of this intervention.
study aims to develop a process- and service-focused implementation
model in collaboration with key stakeholders and bring together
peer-reviewed literature, practice-based knowledge, and expert opinions.
simple rules for evidence translation in complex systems framework was
applied to guide the development of a 6-step qualitative study. The
steps were definition of the scope and objectives of the model,
identification of evidence, stakeholder engagement, draft model
development, key informant consultation, and final model specification.
final specification for the TMOUD implementation model incorporated key
strategic priorities, service delivery prerequisites, service design
elements, stakeholder identification and engagement, key process
domains, and iterative cycles of evaluation and improvement.
- Medication for opioid use disorder
- Implementation model
- Opioid use disorder
- Mobile phone